Binaytara

@binaytara.bsky.social

Advancing education, research, and innovation in hematology & oncology. #CancerPrevention #CancerAwareness #CancerSurvivors #CancerCare #HealthEquity #GlobalOncology #GlobalHealth #LGBTQ+🏳️‍🌈💙 Follow Us: https://buff.ly/MWm1IOU

What if the biggest breakthroughs in breast cancer care never reached most patients? Authored by Dr. Sara Zhukovsky and Dr. Christos Vaklavas, this article explores practical, scalable strategies to improve access, adherence, and equity in real-world care. buff.ly/EWQ3P3K #SABCS

Real-World Impact: Applying SABCS 2025 Advances in Community Oncology | Cancer News

Explore how SABCS 2025 innovations—risk-based screening, digital adherence tools, and survivorship platforms—are improving breast cancer care and equity in community oncology settings.

binaytara.org

Met with @binaytara.bsky.social’s leadership team in Nepal—great to see the strong progress being made. We’re expanding our work in cervical cancer screening and gearing up to begin construction of a cancer hospital soon. Exciting times ahead as we continue working to improve access to cancer care.

Bild

The CME/CE-accredited 2026 Best of Hematology, Austin is just around the corner! Join us on May 16 in Austin, TX, for a full day of insights across leukemia, MDS, multiple myeloma, lymphoma, MPNs, and benign hematologic disorders. Register NOW: buff.ly/60UbvMI

Bild

From antibody–drug conjugates (ADCs) moving into earlier, potentially curative settings to the rise of oral SERDs and mutation-guided therapy, this year’s data are already reshaping how oncologists approach treatment in 2026. Read the full breakdown of SABCS 2025’s updates:

Top Clinical Takeaways from SABCS 2025: What Oncologists Need to Know Now | Cancer News

SABCS 2025 introduced major breast cancer advances, including earlier use of antibody–drug conjugates, oral SERDs for endocrine resistance, and mutation-guided therapy strategies shaping oncology…

buff.ly

Virginia Mason providers are leading the charge in advancing cancer health equity at #SCHD26🌍 - highlighting a growing commitment to addressing disparities and improving outcomes for underserved communities. See the takeaways from the experts. binaytara.org/news/news/vi... #HealthEquity #Binaytara

Virginia Mason Providers Lead SCHD26 on Cancer Health Disparities

Virginia Mason Franciscan Health experts led key sessions at SCHD26, driving innovation in patient navigation, chemotherapy education, and global cancer health equity.

binaytara.org

At the #Binaytara Spring Research Day 2026, Gamala Luitel shared insights from the HPV screening initiative in Janakpur, Nepal. Community‑based programs that empower local health workers are critical for improving early detection and prevention of cervical cancer. Support us: buff.ly/OT8Jc32

Bild

💡Congratulations! At the 2026 Summit on Cancer Health Disparities (#SCHD26), we awarded $50,000 in research funding through our first-ever Impact Pitch—a Shark Tank-style competition designed to support early-career investigators tackling cancer health disparities: binaytara.org/news/researc...

Binaytara Awards $50,000 in Cancer Research Funding at SCHD 2026

Binaytara awarded $50,000 in research funding to early-career investigators through the new Impact Pitch competition at the 2026 Summit on Cancer Health Disparities.

binaytara.org

📢Call for Abstracts Now Open - Over $200K in Research Funding Available! Accepted abstracts will be published, and eligible authors can compete in the Impact Pitch: Binaytara Research Award Challenge, with over $200,000 in total research funding available across multiple awards: buff.ly/RXhgNlG

Bild